GlaxoSmithKline’s H1N1 swine flu vaccine Pandemrix made waves around 2010 after increased cases of narcolepsy emerged in Sweden and Finland among children who got it during the previous pandemic. But a recent report by The BMJ suggests greater safety problems with the vaccine, which neither GSK nor health authorities have made public.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,